Tumor/Endothelium Crosstalk Attracts T Cells 40. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, et al. (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154: 3863–3870. 41. Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM (2006) CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell Immunol 243: 19–29. 42. Van CE, Van DJ, Opdenakker G (1999) The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 10: 61–86. 43. Sager R, Haskill S, Anisowicz A, Trask D, Pike MC (1991) GRO: a novel chemotactic cytokine. Adv Exp Med Biol 305: 73–77. 44. Sager R, Anisowicz A, Pike MC, Beckmann P, Smith T (1992) Structural, regulatory, and functional studies of the GRO gene and protein. Cytokines 4: 96–116. 45. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, et al. (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci U S A 100: 13513–13518. 10.1073/pnas.2235846100 [doi];2235846100 [pii]. 46. Ahmed N, Ratnayake M, Savoldo B, Perlaky L, Dotti G, et al. (2007) Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 67: 5957–5964. 47. Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, et al. (2010) HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors. Clin Cancer Res 16: 474–485. 1078- 0432.CCR-09-1322 [pii];10.1158/1078-0432.CCR-09-1322 [doi]. 48. Shu Q, Wong KK, Su JM, Adesina AM, Yu LT, et al. (2008) Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma. Stem Cells 26: 1414–1424. 2007-1009 [pii];10.1634/stemcells.2007-1009 [doi]. 49. Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92: 679–690. PLoS ONE | www.plosone.org 11 May 2011 | Volume 6 | Issue 5 | e20267